News & Updates
Filter by Specialty:

OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies
05 Mar 2024
byAudrey Abella
Omalizumab scores in the NIH*-sponsored phase III OUtMATCH** trial, increasing the threshold for an allergic reaction to peanut and other common food allergens in children and adults with multiple food allergies.